Position in NVO
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$774,231
+$249,258 QoQ
Shares Held
16,150
+13.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#580
of 1,348 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONARCH CAPITAL MANAGEMENT INC holds $54,521,424 across 10 Drug Manufacturers - General names. NVO ranks #8 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
119,322 | $15,332,877 | |
| 2 | JNJ |
Johnson & Johnson
|
57,752 | $14,667,275 | |
| 3 | ABBV |
AbbVie Inc.
|
49,047 | $12,342,187 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
40,685 | $5,140,142 | |
| 5 | PFE |
Pfizer Inc
|
127,572 | $3,071,933 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
23,815 | $1,372,220 | |
| 7 | LLY |
ELI LILLY & Co
|
1,108 | $1,328,968 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
16,150 | $774,231 |
All Filings in NVO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $774,231 | 16,150 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $524,973 | 14,285 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $503,915 | 9,904 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $234,167 | 4,220 | Shares | Sole | 2025-10-20 | |
| No filing history on record for this holder in this stock. | ||||||